SCHEMBL5069162

SCHEMBL5069162

N#CSc1cc(C(=O)O)ccc1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
CDC25B P30305 1/20 0.46
KDM4E B2RXH2 10/20 0.42
ALDH1A1 P00352 5/20 0.42
TDP1 Q9NUW8 3/20 0.42
MAPT P10636 7/20 0.39
POLB P06746 4/20 0.39
USP2 O75604 2/20 0.39
USP8 P40818 1/20 0.39
USP5 P45974 1/20 0.39
USP4 Q13107 1/20 0.39
USP7 Q93009 1/20 0.39
GAA P10253 8/20 0.38
HSD17B10 Q99714 4/20 0.38
THRB P10828 4/20 0.38
GFER P55789 4/20 0.38
HPGD P15428 3/20 0.38
HTT P42858 1/20 0.38
PLEC Q15149 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9730569 0.81 MAPT (0.45) KDM4EALDH1A1TDP1MAPTPOLB
SCHEMBL29128915 0.81 KDM4E (0.43) CDC25BKDM4EALDH1A1TDP1MAPT
SCHEMBL31741292 0.80 CDC25B (0.53) LMNACDC25BKDM4EALDH1A1TDP1
SCHEMBL8124833 0.80 CDC25B (0.53) LMNACDC25BKDM4EALDH1A1TDP1
SCHEMBL13002493 0.79 TSHR (0.44) KDM4EALDH1A1TDP1MAPTPOLB
SCHEMBL24215241 0.78 CDC25B (0.52) LMNACDC25BKDM4EALDH1A1TDP1
SCHEMBL4681611 0.77 LMNA (0.50) LMNAALDH1A1MAPTPOLBHSD17B10
SCHEMBL8124830 0.77 CDC25B (0.50) LMNACDC25BKDM4EALDH1A1TDP1
SCHEMBL7275002 0.77 CDC25B (0.50) LMNACDC25BKDM4EALDH1A1TDP1
SCHEMBL13002491 0.76 TSHR (0.44) KDM4EALDH1A1TDP1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7345180-B2 Compound inhibiting dipeptidyl peptidase IV SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 2008-03-18 US disclosed
US-20060229286-A1 Compound inhibiting dipeptidyl peptidase IV SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 2006-10-12 US disclosed
EP-1595866-A1 COMPOUND INHIBITING DIPEPTIDYL PEPTIDASE IV Sanwa Kagaku Kenkyusho Co., Ltd. (JP) 2005-11-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229286-A1 Compound inhibiting dipeptidyl peptidase IV DPP4, DPP3, DPP7 LMNA 4436/4885CDC25B 4675/4885KDM4E 2352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.